Michael James McClellan, EVP, Chief Financial Officer at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), sold 287 shares at $17.88 ($5K) on 2018-03-19, disclosed to the SEC on 2018-03-20.
Open-market sale of $5k TEVA by EVP, Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| TEVA | SELL | 2019-03-19 | $4K | — | Filing → |
| TEVA | SELL | 2019-03-05 | $6K | — | Filing → |
| TEVA | SELL | 2018-11-07 | $8K | — | Filing → |